Effect of Thiamphenicol on EAAT2 and Other Biomarkers From Nasal Biopsied Tissue

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

September 30, 2007

Study Completion Date

April 30, 2008

Conditions
Healthy
Interventions
DRUG

Thiamphenicol

750 and 1500 mg/day;tablets

DRUG

Placebo

Matched tablets without active ingredient

Trial Locations (1)

Unknown

SGS Research Unit - Stuivenberg, Antwerp

All Listed Sponsors
collaborator

SGS Life Sciences, a division of SGS Belgium NV

OTHER

lead

Psyadon Pharma

INDUSTRY

NCT00958503 - Effect of Thiamphenicol on EAAT2 and Other Biomarkers From Nasal Biopsied Tissue | Biotech Hunter | Biotech Hunter